Does Mounjaro cause muscle loss, and what can you do about it?

What actually happens to muscle when you lose weight on Mounjaro?

Every form of meaningful weight loss (calorie restriction, bariatric surgery, or GLP-1 treatment) tends to reduce some lean mass alongside fat. Muscle loss on Mounjaro follows the same pattern. In the SURMOUNT-1 trial, participants losing around 20% of body weight at the 15mg dose lost a proportion of that as lean tissue, consistent with what's seen in other large weight-loss interventions. The key question isn't whether any lean mass is lost; it's what fraction.

Tirzepatide works partly by reducing appetite substantially, which means total calorie intake drops. When the body runs a sustained energy deficit, it draws on both fat stores and, to a lesser degree, muscle protein. The size of that lean-mass fraction depends heavily on how much protein you eat, how active you are, and how fast weight is coming off. Rapid loss tends to take more muscle; slower, protein-adequate loss takes less. The tirzepatide overview on our site covers how the medicine works in more detail if that's useful context.

One note our prescribers hear most weeks: patients worry they're "losing muscle" when they feel physically weaker in the first few weeks. Fatigue is a recognised side effect of early treatment and isn't the same as structural muscle loss, the two feel similar but have different causes. Muscle ache during Mounjaro treatment is covered separately, because the management differs.

The three levers that protect lean mass during treatment

Framing this as a decision helps: you can't prevent all lean-mass loss during significant weight reduction, but you can shift the ratio meaningfully. Three factors do most of the work.

Protein intake. Skeletal muscle needs adequate dietary protein to maintain and rebuild itself. During a calorie deficit, keeping protein high (typically 1.2–1.6 g per kilogram of body weight per day is a range clinicians often discuss, though your prescriber or dietitian should guide your personal target) signals the body to preserve lean tissue rather than break it down for fuel. Appetite suppression from tirzepatide can make hitting protein targets harder; prioritising protein-dense foods early in each meal, before fullness sets in, is a practical workaround.

Resistance exercise. Strength training sends a direct signal to retain and build muscle even in a deficit. Even two sessions per week of bodyweight exercises, resistance bands, or weights provides a meaningful stimulus. Cardiovascular activity matters for general health but does relatively little to preserve lean mass compared with load-bearing movement.

Rate of loss. Losing weight faster than roughly 0.5–1% of body weight per week increases the proportion lost as lean tissue. If your rate of loss is very fast, that's worth discussing with your prescriber at review, dose titration and dietary adjustments can be considered. You can read more about the Mounjaro treatment journey to understand how dose steps work in practice.

Muscle pain on Mounjaro: a separate question

Muscle pain with Mounjaro is a different concern from muscle loss, and it's worth distinguishing them clearly. Tirzepatide is not associated with the muscle toxicity risks linked to some other drug classes (statins, for example, carry a rare myopathy risk). Reported Mounjaro muscle aches in clinical trial data tend to be mild and related to the general side-effect profile (fatigue, headache, injection-site reactions) rather than direct muscle damage.

If you develop severe or persistent muscle pain, weakness, or dark-coloured urine during treatment, that warrants prompt medical review; report any suspected side effects via the MHRA Yellow Card scheme. Mild muscle discomfort that tracks with dose increases and settles within a week or two is common and usually benign. Your prescriber can help you tell the difference at clinical review.

The NHS guidance on tirzepatide lists the recognised side effects in full, the NHS tirzepatide medicine page is the clearest plain-English reference. For questions about your specific situation, the treatment FAQs cover a range of common concerns, and our team is reachable via the contact page seven days a week.

When to raise muscle loss concerns with your prescriber

Regular clinical review is built into treatment at nume, not bolted on as an afterthought. Before any repeat prescription is issued, a GPhC-registered Independent Prescriber considers how you're progressing, including whether the rate of weight loss looks appropriate and whether any symptoms need attention. That's the right moment to raise concerns about muscle loss with Mounjaro, changes in strength, or muscle pain.

If you're considering treatment and want to understand how the clinical process works before committing, a free consultation with our prescribers is the starting point, no obligation, and questions about muscle health are exactly the kind of thing worth raising there. For context on what treatment typically costs and what's included in the price, the weight-loss treatment overview explains the structure clearly. The detailed question of whether Mounjaro causes muscle loss and what the trial evidence shows specifically are covered in companion pages if you want to go deeper on the data.